88 FR 33 pgs. 10382-10383 - Importer of Controlled Substances Application: Mylan Inc.
Type: NOTICEVolume: 88Number: 33Pages: 10382 - 10383
Pages: 10382, 10383Docket number: [Docket No. 1140]
FR document: [FR Doc. 2023-03395 Filed 2-16-23; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 1140]
Importer of Controlled Substances Application: Mylan Inc.
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Mylan Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 20, 2023. Such persons may also file a written request for a hearing on the application on or before March 20, 2023.
ADDRESSES:
[top] The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal,
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on December 2, 2022, Mylan Inc., 3711 Collins Ferry Road, Morgantown, West Virginia 26505-2362, applied to be registered as an importer of the following basic class(es) of controlled substance(s):
Controlled substance | Drug code | Schedule |
---|---|---|
Amphetamine | 1100 | II |
Methylphenidate | 1724 | II |
Oxycodone | 9143 | II |
Hydromorphone | 9150 | II |
Methadone | 9250 | II |
Morphine | 9300 | II |
Fentanyl | 9801 | II |
The company plans to import bulk active pharmaceutical ingredients for internal testing purposes only and finished dosage forms for analytical testing and distribution for clinical trials. No other activity for these drug codes is authorized for this registration.
Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the import of the Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-03395 Filed 2-16-23; 8:45 am]
BILLING CODE P